FutureChem: Clinical Trials

3 trials sponsored by FutureChem, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow FutureChem: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
[177Lu]Ludotadipep 3.7 GBq - Metastatic Castration-resistant Prostate Cancer
Phase 1 / Phase 2UnknownFutureChem262022-09-012024-04-29
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
[18F]FLOR (FC303) Injection - Metastatic Prostate Cancer
Phase 1TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins82021-02-012024-01-16
[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.
[177Lu]Ludotadipep - Metastatic Castration-resistant Prostate Cancer
Phase 1CompletedFutureChem302020-10-142022-10-20

Conditions studied

Prostatic Neoplasms (2)

Interventions

Injections (1)

Countries

United States (2)  ·  South Korea (1)

Top investigators

Arif Hussain, MD (1)  ·  Ji Youl Lee (1)  ·  Steven Rowe, M.D., Ph.D. (1)